Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma.

Cancer science - 1 Jul 2007

Shibata Tatsuhiro, Hanada Satoko, Kokubu Akiko, Matsuno Yoshihiro, Asamura Hisao, Ohta Tsutomu, Sakamoto Michiie, Hirohashi Setsuo

Abstract excerpt

We examined the genome-wide expression profiles of 86 primary lung adenocarcinomas and compared them with the mutation status of the four key molecules (EGFR, ERBB2, KRAS and BRAF) in the EGFR/KRAS/BRAF pathway. Unsupervised classification revealed two subtypes (the bronchial type and the alveola...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to ErbB Receptors
Share to Genes, ras

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 17459062
DOI: 10.1111/j.1349-7006.2007.00483.x
PMCID: PMC11159808

Genes

EGFR
KRAS
BRAF
BCR
AKT1
EGF
ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17459062-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma.PMID 17459062Read ↗

Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomasSemantic proximity Read ↗

Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas.Semantic proximity Read ↗

Lung adenocarcinoma subtypes based on expression of human airway basal cell genes.Semantic proximity Read ↗

EGFR gene deregulation mechanisms in lung adenocarcinoma: A molecular reviewSemantic proximity Read ↗

Identification of Subsets of Genetic Alterations in KRAS-mutant Lung Cancer using Association Rule MiningSemantic proximity Read ↗

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors.Semantic proximity Read ↗

Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining.Semantic proximity Read ↗

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.Semantic proximity Read ↗

Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer.Semantic proximity Read ↗

Somatic mutations affect key pathways in lung adenocarcinoma.Semantic proximity Read ↗

A gene-alteration profile of human lung cancer cell lines.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.